22 Feb 15

Letters To USA Today article Respond On High Price of new cancer drugsTwo letters to the editor of USA Today on Tuesday responded to an article published on 11 Published in July, examined how the high price of new cancer drugs – as much as $ 10,000 per month for a treatment – concerns for patients and raised raised ed pump . Summaries of the letters displayed below. Robert Goldberg: The article explains that since most new drugs are not do of cancer in most patients, they should not be so expensive healing Goldberg, vice president of the Center for Science in the Public Interest writes. But according to Goldberg, new cancer drugs increased the life expectancy of people with cancer by about a year diagnosed between 1975 and 1995, and the mortality rate from this disease has decreased faster since 1995 than at any other time, according to Goldberg. He adds that the article on studies that proven drugs for specific groups from the results of the one-size-fits-all studies have proven rather than studies that focus matched the right drug to the right patient, the disease progresses the disease progresses. Goldberg concludes, USA Today to shell out money to shell out money for cancer drugs asks. To study the question of why health plans the entire cost of the entire cost of cheaper and less effective drugs but have Avastin (Goldberg, USA Today.

courtesy of you, the entire Kaiser Daily Health Policy Report view reserved, search the archives, or sign up for email delivery at Kaiser Daily Health Policy Report strongly supports imperial network. A free service of the Henry J. Published. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


By courtesy of to can total Kaiser Daily Health Policy see Report search the archives or sign up for mail notification at Emperor Daily Health policy coverage strongly supported emperor network. A free service from the Henry J. Publishes. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Brasil did prepare a study about the feasibility of establishing a $ 23000000 about production pharmaceutical factory in Mozambique to drugs for HIV / AIDS determine, malaria and other diseases, an unnamed spokesman Brazilian Ministry of Health said am Dienstag , reports the Reuters news agency. The spokesman also said to Brazilian have offered to offer technology, training and monitoring of the plant.